In today’s rapidly evolving regulatory landscape, analytical impurities have become a critical concern for professionals in pharmaceuticals, biotechnology, cosmetics, and medical devices. Uncontrolled impurities can compromise product quality, lead to costly non-compliance issues, and jeopardise patient or consumer safety.
Are you confident in your laboratory’s approach to impurities?
Even the most advanced R&D or production environment is exposed to risks when it comes to identifying, quantifying, and controlling impurities. From trace contaminants in raw materials to by-products formed during manufacturing or storage, the sources of risk are numerous and often underestimated.
Join our expert webinar
To help you navigate these challenges, GenEvolutioN is proud to host a 30-minute live webinar in partnership with CEFIRA:
Date: July 1, 2025
Time: 11:30 am > 12:00 pm
Key topics covered:
- The latest regulatory frameworks and international standards for impurity management
- Analytical strategies for detecting and quantifying impurities (ICH Q3A/B, EMA, FDA, etc.)
- Best practices for laboratory compliance and avoiding non-conformities
- Real-world examples: how uncontrolled impurities can lead to recalls, regulatory action, or product failure
- Q&A session: get your questions answered live by Gautier Decock, General Manager at GenEvolutioN
Who should attend?
- QA/QC Managers
- R&D and Analytical Scientists
- Regulatory Affairs Professionals
- Laboratory Managers
- Anyone involved in product development or compliance in Pharma, Biotech, Cosmetics, or Medical Devices
Why is this important?
Regulatory authorities are tightening requirements and increasing audits. A minor oversight in impurity management can lead to significant business, legal, and reputational consequences. Staying updated and proactive is essential.
Secure your spot now – places are limited!
Can’t attend live? Register anyway to receive the replay.
